Ulcerated Lichen Planus after Adjuvant Use of Programmed Cell Death-1-Inhibitor: A Case Report and Systematic Review of the Literature

Acta Derm Venereol. 2021 Jun 2;101(6):adv00472. doi: 10.2340/00015555-3840.
No abstract available

Keywords: anti-PD-1; anti-PD-L1; immune-related adverse event; melanoma; pembrolizumab; lichen planus.

Publication types

  • Case Reports
  • Systematic Review

MeSH terms

  • Apoptosis
  • B7-H1 Antigen
  • Humans
  • Lichen Planus* / chemically induced
  • Lichen Planus* / diagnosis
  • Lichen Planus* / drug therapy
  • Nivolumab

Substances

  • B7-H1 Antigen
  • Nivolumab